Your browser doesn't support javascript.
loading
Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy.
Akhtar, Md Sayeed; Pillai, Krishna Kolappa; Hassan, Quamrul; Ansari, Shahid Husain; Ali, Javed; Akhtar, Mohammed; Najmi, Abul Kalam.
Afiliación
  • Akhtar MS; a Department of Pharmacology .
  • Pillai KK; a Department of Pharmacology .
  • Hassan Q; a Department of Pharmacology .
  • Ansari SH; b Department of Pharmacognosy , and.
  • Ali J; c Department of Pharmaceutics, Faculty of Pharmacy , Jamia Hamdard , New Delhi , India.
  • Akhtar M; a Department of Pharmacology .
  • Najmi AK; a Department of Pharmacology .
Clin Exp Hypertens ; 38(1): 10-22, 2016.
Article en En | MEDLINE | ID: mdl-26207881

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piridazinas / Ramipril / Apoptosis / Estrés Oxidativo / Diabetes Mellitus Experimental / Cardiomiopatías Diabéticas / Hidrazonas Límite: Animals Idioma: En Revista: Clin Exp Hypertens Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piridazinas / Ramipril / Apoptosis / Estrés Oxidativo / Diabetes Mellitus Experimental / Cardiomiopatías Diabéticas / Hidrazonas Límite: Animals Idioma: En Revista: Clin Exp Hypertens Año: 2016 Tipo del documento: Article